URGN earnings
UroGen Pharma (URGN) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
URGN earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | -0.28 | -0.27 | -5.66% | $72.46M |
| Q1 2026 | May 6, 2026 | -0.47 | -0.56 | 16.07% | $50.96M |
| Q4 2025 | Mar 2, 2026 | -0.54 | -0.52 | -4.25% | $37.84M |
| Q3 2025 | Nov 6, 2025 | -0.69 | -0.72 | 4.17% | $27.48M |
| Q2 2025 | Aug 7, 2025 | -1.05 | -0.82 | -28.05% | $24.21M |
| Q1 2025 | May 12, 2025 | -0.92 | -0.83 | -10.84% | $20.25M |
| Q4 2024 | Mar 10, 2025 | -0.80 | -0.69 | -15.94% | $24.57M |
| Q3 2024 | Nov 6, 2024 | -0.55 | -0.84 | 34.52% | $25.20M |
| Q2 2024 | Aug 13, 2024 | -0.91 | -0.82 | -10.98% | $21.85M |
| Q1 2024 | May 13, 2024 | -0.97 | -0.93 | -4.30% | $18.78M |
| Q4 2023 | Mar 14, 2024 | -0.72 | -0.67 | -7.46% | $23.53M |
| Q3 2023 | Nov 14, 2023 | -0.68 | -0.89 | 23.60% | $20.85M |
| Aug 10, 2023 | -1.03 | -1.13 | 8.85% | – | |
| May 11, 2023 | -1.30 | -1.39 | 6.47% | – | |
| Mar 16, 2023 | -1.22 | -1.12 | -8.93% | – | |
| Nov 10, 2022 | -1.13 | -1.22 | 7.38% | – | |
| Aug 11, 2022 | -1.18 | -1.33 | 11.28% | – | |
| May 10, 2022 | -1.25 | -1.36 | 8.09% | – | |
| Mar 21, 2022 | -1.27 | -1.18 | -7.63% | – | |
| Nov 15, 2021 | -1.35 | -1.26 | -7.14% | – |
- URGN reports next on Nov 4, 2026, with EPS of 0.13 expected.
- URGN beat EPS estimates in 15 of its last 37 reports.
Updated 2026-11-02 23:14 UTC